X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare, Analyse Cadila Healthcare with ADCOCK INGRAM HOLDINGS LTD. - S. Africa - Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

CADILA HEALTHCARE vs ADCOCK INGRAM (S. Africa) - Comparison Results

CADILA HEALTHCARE    Change

Cadila Healthcare is one of the leading players in the Indian pharma market having a presence in both the domestic and international markets. In the international markets, the company had adopted the strategy of competing directly in the generics mar... More

ADCOCK INGRAM (S. Africa)
   Change

Adcock Ingram is a leading South African pharmaceutical manufacturer, marketer and distributor. The company occupies 10% share of the private pharmaceutical market in South Africa with a strong presence in over-the-counter (OTC) brands. Adcock is als... More

DO YOU LIKE THESE REPORTS? TELL US!

Financials

 CADILA HEALTHCARE   ADCOCK INGRAM
EQUITY SHARE DATA
    CADILA HEALTHCARE
Mar-17
ADCOCK INGRAM
Jun-14
CADILA HEALTHCARE/
ADCOCK INGRAM
5-Yr Chart
Click to enlarge
High Rs460379-   
Low Rs305274-   
Sales per share (Unadj.) Rs92.1112.8-  
Earnings per share (Unadj.) Rs14.8-28.4-  
Cash flow per share (Unadj.) Rs18.5-23.6-  
Dividends per share (Unadj.) Rs3.200-  
Dividend yield (eoy) %0.80-  
Book value per share (Unadj.) Rs68.088.5-  
Shares outstanding (eoy) m1,023.74168.78-   
Bonus/Rights/Conversions ---  
Price / Sales ratio x4.22.9 143.5%   
Avg P/E ratio x25.8-11.5 -224.8%  
P/CF ratio (eoy) x20.7-13.9 -149.4%  
Price / Book Value ratio x5.63.7 152.6%  
Dividend payout %21.60-   
Avg Mkt Cap Rs m391,58155,082 710.9%   
No. of employees `00016.94.3 392.6%   
Total wages/salary Rs m15,0023,457 434.0%   
Avg. sales/employee Rs Th5,594.54,434.5 126.2%   
Avg. wages/employee Rs Th890.1805.3 110.5%   
Avg. net profit/employee Rs Th899.9-1,117.4 -80.5%   
INCOME DATA
Net Sales Rs m94,29519,037 495.3%  
Other income Rs m1,286133 964.6%   
Total revenues Rs m95,58119,171 498.6%   
Gross profit Rs m19,036-3,299 -577.0%  
Depreciation Rs m3,750822 456.4%   
Interest Rs m450516 87.3%   
Profit before tax Rs m16,122-4,503 -358.0%   
Minority Interest Rs m338-13 -2,692.8%   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m-30-   
Tax Rs m1,289281 458.1%   
Profit after tax Rs m15,168-4,797 -316.2%  
Gross profit margin %20.2-17.3 -116.5%  
Effective tax rate %8.0-6.2 -128.0%   
Net profit margin %16.1-25.2 -63.8%  
BALANCE SHEET DATA
Current assets Rs m60,22313,943 431.9%   
Current liabilities Rs m53,0587,845 676.3%   
Net working cap to sales %7.632.0 23.7%  
Current ratio x1.11.8 63.9%  
Inventory Days Days70111 63.0%  
Debtors Days Days88124 71.1%  
Net fixed assets Rs m72,9848,127 898.0%   
Share capital Rs m1,02488 1,158.5%   
"Free" reserves Rs m68,5760-   
Net worth Rs m69,60014,942 465.8%   
Long term debt Rs m24,6845,251 470.1%   
Total assets Rs m152,20728,227 539.2%  
Interest coverage x36.8-7.7 -476.3%   
Debt to equity ratio x0.40.4 100.9%  
Sales to assets ratio x0.60.7 91.9%   
Return on assets %10.3-15.2 -67.7%  
Return on equity %21.8-32.1 -67.9%  
Return on capital %17.9-19.8 -90.5%  
Exports to sales %00-   
Imports to sales %00-   
Net fx Rs m10,4060-   
CASH FLOW
From Operations Rs m13,4951,625 830.5%  
From Investments Rs m-29,103-499 5,832.9%  
From Financial Activity Rs m23,1584,766 485.9%  
Net Cashflow Rs m7,5565,892 128.3%  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster
The reporting currency for ADCOCK INGRAM (S. Africa) is South Africa Rand. All data has been converted at 5.23 Rs / ZAR

Compare CADILA HEALTHCARE With: ACTAVIS (US)  MYLAN (US)  TEVA PHARMA (Israel)  

Compare CADILA HEALTHCARE With: ORCHID PHARMA LTD  IPCA LABS  DIVIS LABORATORIES  PIRAMAL ENTERPRISES  SHASUN PHARMA  



Today's Market

Of Global Markets Hitting Record Highs and Top Stocks in Action During the Week(RoundUp)

Global stock markets ended the week on a positive note. Benchmark indices in US grew by 1% during the week. The Down Jones Industrial Average topped the 26,000.

Related Views On News

Sun Pharma: Tough US Scenario Continues to Hit Business (Quarterly Results Update - Detailed)

Nov 20, 2017

The company's India business recovers but the pricing pressure and USFDA issues continue to mar the US revenues.

Dr Reddy's: No Respite from Pricing Pressure in the US (Quarterly Results Update - Detailed)

Nov 13, 2017

Pricing pressure continued to haunt Dr Reddy's although there was a significant improvement in its businesses sequentially.

Cipla: Strong Recovery Post GST (Quarterly Results Update - Detailed)

Nov 10, 2017

Cipla's India business recovers strongly this quarter post the GST issues in the first quarter of this fiscal.

Glenmark: Most Geographies Show Weak Growth (Quarterly Results Update - Detailed)

Nov 7, 2017

Poor show in the US, Latam and India hit profits during the quarter.

Lupin: US Markets Drags down Revenues and Net Profits (Quarterly Results Update - Detailed)

Nov 2, 2017

Domestic markets registers robust growth in the quarter

More Views on News

Most Popular

Retail Investors or Chickens Waiting to Get Slaughtered in the Stock Market?(Vivek Kaul's Diary)

Jan 9, 2018

The price to earnings ratio of the Nifty 50 is very close to all-time high levels.

Best ELSS Funds In 2018: Don't Blindly Chase Top Performers(Outside View)

Jan 10, 2018

As the tax-saving season begins, investors hunt for the best ELSS funds for 2018. PersonalFN provides a list of the top ELSS mutual funds of the past year.

Did GST and Notebandi Help? Sherlock Holmes Finds Out...(The 5 Minute Wrapup)

Jan 13, 2018

Discussions with my cousin helped me understand the situation on Ground Zero - after the demonetization and GST upheaval. Here's what that means for listed companies...

Resolutions for 2018 - by others(The Honest Truth)

Jan 8, 2018

Ten quirky new year resolutions. Guess by whom?

Bitcoin Beginners Should Do These Three Things...(Smart Contrarian)

Jan 10, 2018

Three simple points to keep in mind before you consider buying bitcoin.

More

Small Investments
BIG Returns

Zero To Millions Guide 2018
Get our special report, Zero To Millions
(2018 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

CADILA HEALTHCARE SHARE PRICE


Jan 19, 2018 (Close)

TRACK CADILA HEALTHCARE

  • Track your investment in CADILA HEALTHCARE with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON CADILA HEALTHCARE

CADILA HEALTHCARE - NATCO PHARMA COMPARISON

COMPARE CADILA HEALTHCARE WITH

MARKET STATS